Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
- PMID: 17141630
- DOI: 10.1016/j.cmet.2006.11.005
Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
Abstract
Elevated levels of tumor necrosis factor (TNFalpha) are implicated in the development of insulin resistance, but the mechanisms mediating these chronic effects are not completely understood. We demonstrate that TNFalpha signaling through TNF receptor (TNFR) 1 suppresses AMPK activity via transcriptional upregulation of protein phosphatase 2C (PP2C). This in turn reduces ACC phosphorylation, suppressing fatty-acid oxidation, increasing intramuscular diacylglycerol accumulation, and causing insulin resistance in skeletal muscle, effects observed both in vitro and in vivo. Importantly even at pathologically elevated levels of TNFalpha observed in obesity, the suppressive effects of TNFalpha on AMPK signaling are reversed in mice null for both TNFR1 and 2 or following treatment with a TNFalpha neutralizing antibody. Our data demonstrate that AMPK is an important TNFalpha signaling target and is a contributing factor to the suppression of fatty-acid oxidation and the development of lipid-induced insulin resistance in obesity.
Similar articles
-
Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle.Diabetes. 2017 Jul;66(7):1858-1870. doi: 10.2337/db16-0270. Epub 2017 Apr 12. Diabetes. 2017. PMID: 28404596 Free PMC article.
-
Increased susceptibility to acute kidney injury due to endoplasmic reticulum stress in mice lacking tumor necrosis factor-α and its receptor 1.Kidney Int. 2011 Mar;79(6):613-623. doi: 10.1038/ki.2010.469. Epub 2010 Dec 8. Kidney Int. 2011. PMID: 21150875
-
Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.J Biol Chem. 2007 Jul 6;282(27):19302-12. doi: 10.1074/jbc.M700665200. Epub 2007 May 11. J Biol Chem. 2007. PMID: 17500068
-
Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance.Cell Cycle. 2007 Apr 15;6(8):888-94. doi: 10.4161/cc.6.8.4135. Epub 2007 Apr 11. Cell Cycle. 2007. PMID: 17438370 Review.
-
The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.Acta Physiol (Oxf). 2006 Jan;186(1):5-16. doi: 10.1111/j.1748-1716.2005.01502.x. Acta Physiol (Oxf). 2006. PMID: 16497175 Review.
Cited by
-
AMPK as a mediator of tissue preservation: time for a shift in dogma?Nat Rev Endocrinol. 2024 May 17. doi: 10.1038/s41574-024-00992-y. Online ahead of print. Nat Rev Endocrinol. 2024. PMID: 38760482 Review.
-
COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights.Pathophysiology. 2024 Apr 8;31(2):197-209. doi: 10.3390/pathophysiology31020016. Pathophysiology. 2024. PMID: 38651404 Free PMC article. Review.
-
Regulation of proteostasis and innate immunity via mitochondria-nuclear communication.J Cell Biol. 2024 Mar 4;223(3):e202310005. doi: 10.1083/jcb.202310005. Epub 2024 Feb 9. J Cell Biol. 2024. PMID: 38335010 Free PMC article. Review.
-
Short salsalate administration affects cell proliferation, metabolism, and inflammation in polycystic kidney disease.iScience. 2023 Oct 19;26(11):108278. doi: 10.1016/j.isci.2023.108278. eCollection 2023 Nov 17. iScience. 2023. PMID: 38026227 Free PMC article.
-
Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study.BMC Pulm Med. 2023 Oct 18;23(1):394. doi: 10.1186/s12890-023-02702-2. BMC Pulm Med. 2023. PMID: 37853348 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases